whats in klow EllieMD KLOW: Understanding the Peptide Stack
Description
doi:10.1016/j.anai.2013.09.016
Front Nutr , 11 , 1322509
NLs, Neuroligins
For instance, initiating TIGIT inhibitor treatment when T cells show signs of exhaustion, using CSF-1R inhibitors when MDSC activity increases, or promptly adopting dual ICI strategies on the basis of baseline high-risk genomic features
